BDA 366
BDA-366 specifically targets the BH4 domain of Bcl2 BDA-366 and suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change.
Product Specifications
CAS Number
1821496-27-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
423.26
Molecular Formula
C24H29N3O4
Notes
Research use only, not for human use.
Receptor
Bcl-2-BH4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog